CureVac N.V. (CVAC)
NASDAQ: CVAC · Real-Time Price · USD
3.435
+0.040 (1.18%)
May 14, 2025, 10:48 AM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Transformative Medicines Based on Messenger Ribonucleic Acid
58.12M
Log In
Log In
Log In
Log In
Upgrade
Transformative Medicines Based on Messenger Ribonucleic Acid Growth
-17.98%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Belgium
50.95M
Log In
Log In
Log In
Log In
Upgrade
Belgium Growth
-22.14%
Log In
Log In
Log In
Log In
Upgrade
Switzerland
5.87M
Log In
Log In
Log In
Log In
Upgrade
Switzerland Growth
65.60%
Log In
Log In
Log In
Log In
Upgrade
Netherlands
1.29M
Log In
Log In
Log In
Log In
Upgrade
Netherlands Growth
-31.10%
Log In
Log In
Log In
Log In
Upgrade
Other
8.65K
Log In
Log In
Log In
Log In
Upgrade
Germany
-
Log In
Log In
Log In
Log In
Upgrade
Germany Growth
-
Log In
Log In
Log In
Log In
Upgrade
United States
-
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-
Log In
Log In
Log In
Log In
Upgrade